Download Cardiovascular Medicine 2017

This program is among the
highest-rated Harvard Medical
School CME courses.
Cardiovascular Medicine 2017
Updates for the Practitioner
APRIL 30 - MAY 4
BOSTON, MA
New Findings and Advances for:
• Atherosclerosis, CAD, and inflammation
• Antithrombotic and antiplatelet agents
• Advanced heart failure and cardiomyopathy
• Devices and procedures in the cardiac
cath lab, including TAVR and transcatheter
mitral valve therapies
• Electrophysiology interventions
• Valvular heart disease
•V
ascular medicine, including PAD, diseases
of the aorta, and vasculitis
• Confronting challenges in atrial fibrillation
Under the direction of
Samuel Z. Goldhaber, MD
Peter Libby, MD
Patrick O’Gara, MD
>> Diagnosis and treatment of vascular emergencies
such as dissection of the aorta and acute massive/
submassive pulmonary embolism >> Case-based approaches to heart failure
management >> Emerging imaging and therapeutic technologies >> Intersection of cardiovascular medicine with
internal medicine
Earn up to 39.50 AMA PRA Category 1 Credits™
Register at Cardiovascular.HMSCME.com
Reasons to
attend
Dear Colleague:
On behalf of Brigham and Women’s Hospital and Harvard Medical School, I
invite you to attend the acclaimed biennial course, Cardiovascular Medicine 2017:
Updates for the Practitioner.
You can rely on this comprehensive program for critical updates and practice
recommendations in all major areas of cardiovascular medicine, including:
• Atherosclerosis: prevention and
inflammation
• Ventricular arrhythmias, ICDs and
pacemakers
• Valvular heart disease
• Pulmonary embolism and
pulmonary hypertension
• Advanced heart failure and
cardiomyopathy
• Atrial fibrillation
• Cardio-oncology
• Vascular medicine, including
peripheral artery disease,
hypertension, aortic dissection, and
vasculitis
Our faculty, world-renowned for their clinical, research and teaching achievements,
cover recent advances and current controversies in:
• Stroke prevention and treatment, including management tips for patients with
atrial fibrillation
• Mechanical circulatory support
• Novel oral anticoagulants and antiplatelet agents
• Integrated multimodality cardiovascular imaging
• Management of obstructive sleep apnea and its cardiovascular consequences
• Late-breaking information regarding cardiovascular benefits and risks of antidiabetic drugs
With so many rapid advances in cardiovascular medicine, it is critically important to
ensure your knowledge is both current and comprehensive. Our course provides new
and returning attendees the opportunity to learn and interact closely with our faculty.
Sincerely yours,
• New guidelines and practice
recommendations for lipid therapy
with PCSK9 inhibitors and
advanced heart failure therapies
• Approaches to tailoring
multimodality cardiovascular
imaging to the patient: how to
deploy magnetic resonance,
coronary CT, nuclear imaging, and
echocardiography
• New findings for how general
cardiologists should troubleshoot
problems with pacemakers and
ICDs
• New strategies to minimize
hospital readmission rates for
congestive heart failure
• Determine when to refer patients
for combination therapy of
idiopathic pulmonary hypertension
and which combinations of drugs
are most successful
• Cardiovascular screening and
safety in athletes
• Cardiovascular management of
high-risk pregnancy
• Advances in amyloidosis diagnosis
and treatment
• Update on pericardial diseases
Samuel Z. Goldhaber, MD
Course Director
Professor of Medicine, Harvard Medical School
Section Head, Vascular Medicine, Cardiovascular Division
Brigham and Women’s Hospital
Register at Cardiovascular.HMSCME.com
Cardiovascular Medicine 2017
APRIL 30 - MAY 4
Updates for the Practitioner
SUNDAY • APRIL 30, 2017
Course Description
This course is an intensive and comprehensive review of cardiovascular
medicine geared to mid-career practitioners.
The objective of this 5-day course is to provide a concise, state-of-theart overview of the epidemiology, diagnosis, treatment, and prevention
of cardiovascular disease, with focused sessions on atherosclerosis,
acute coronary syndromes, congestive heart failure, cardiomyopathy,
electrophysiology, vascular medicine, venous thromboembolism,
cardiovascular imaging, and valvular heart disease.
Who Should Attend
Physicians, Nurse Practitioners, Physician Assistants and Pharmacists
in the following fields:
• Cardiology
• Vascular Medicine
• Internal Medicine
• Hospital Medicine
• Family Medicine
• Emergency Medicine
• Gerontology
• Critical Care Medicine
• Interventional Cardiology
ACCREDITATION
The Harvard Medical School is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for
physicians.
The Harvard Medical School designates this live activity for a maximum of
39.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AMERICAN ACADEMY OF FAMILY PHYSICIANS
Application for CME credit has been filed with the American Academy of Family
Physicians. Determination of credit is pending.
CANADIAN ACCREDITATION
The Royal College of Physicians and Surgeons of Canada recognizes conferences
and workshops held outside of Canada that are developed by a university,
academy, hospital, specialty society or college as accredited group learning
activities.
EUROPEAN ACCREDITATION
Through an agreement between the American Medical Association and the
European Union of Medical Specialists, physicians may convert AMA PRA
Category 1 Credit™ to an equivalent number of European CME Credits®
(ECMECs®). Information on the process of converting AMA PRA Category 1
Credits™ to ECMECs® can be found at: www.eaccme.eu.
BOSTON, MA
6:30 am Registration and Breakfast
8:00 am Welcome, Introductions, Course Objectives
Samuel Z. Goldhaber, MD; Peter Libby, MD;
Patrick O’Gara, MD; Calum A. MacRae, MD, PhD
7:45 amSeating
ATHEROSCLEROSIS, INFLAMMATION, THROMBOSIS, AND RISK FACTORS
Session Chairs: Samuel Z. Goldhaber, MD and Patrick O’Gara, MD
8:15 am
8:50 am
9:00 am
9:35 am 9:45 am
10:20 am
10:30 am
Pathophysiology of Acute Myocardial Infarction: Review
of Plaque Rupture; New Insights into Superficial Erosion;
Correlation of Pathophysiology with Patient Profile
Peter Libby, MD
Discussion, Q&A
Targeting and Reducing Inflammation in Atherothrombosis:
JUPITER, CANTOS, and CIRT Trials
Paul M Ridker, MD, MPH
Discussion, Q&A
Rapid-Fire Lipid Disorder Cases: Low HDL, High Triglycerides,
Lack of Statin Adherence, PCSK9 Inhibitors
Jorge Plutzky, MD
Discussion, Q&A
Coffee Break (refreshments provided)
THOMAS W. SMITH, MD MEMORIAL LECTURE
Session Chair: Peter Libby, MD
10:50 am
11:40 am 11:50 am
Diabetic Cardiomyopathy: Foxglove, FoxO, and Failure
Joseph A. Hill, MD, PhD
Discussion, Q&A
Lunch Break
VALVULAR HEART DISEASE SYMPOSIUM
Session Chair: Deepak L. Bhatt, MD, MPH
1:00 pm
1:35 pm
1:45 pm
2:20 pm
Mitral Valve Disease: Hemodynamics, Clinical Assessment, and
Guidelines
Patrick O’Gara, MD
Discussion, Q&A
Transcatheter Aortic and Mitral Valve Therapies
Pinak B. Shah, MD
Discussion, Q&A
EUGENE BRAUNWALD, MD LECTURE
Session Chair: Patrick O’Gara, MD
2:30 pm
3:10 pm
3:20 pm
Congestive Heart Failure: The Past, the Present, and the Future
Eugene Braunwald, MD
Discussion, Q&A
Snack Break (refreshments provided)
ATRIAL FIBRILLATION
Session Chair: Laurence M. Epstein, MD
3:40 pm
ABMS/ACGME COMPETENCIES
This course is designed to meet one or more of the following American Board of
Medical Specialties and Accreditation Council of Graduate Medical Education
competencies: medical knowledge, and practice-based learning and improvement.
Stroke Prevention in Atrial Fibrillation: Warfarin, Antiplatelet
Therapy, and Novel Oral Anticoagulants: Where Do We Stand?
Has the Dust Settled?
Christian T. Ruff, MD, MPH
IOM COMPETENCIES
This course is designed to meet one or more of the following Institute of Medicine
competencies: provide patient-centered care, employ evidence-based practice,
and utilize informatics.
Atrial Fibrillation: Rate versus Rhythm Control, Antiarrhythmic
Therapy, Ablation, and Left Atrial Appendage Occlusion
Gregory Michaud, MD
4:15 pm
4:25 pm 5:00 pm
5:10 pm
5:45 pm
5:55 pm Discussion, Q&A
Discussion, Q&A
The Genetics of Atrial Fibrillation
Calum A. MacRae, MD, PhD
Discussion, Q&A
ADJOURN DAY 1
Cardiovascular Medicine 2017
APRIL 30 - MAY 4
Updates for the Practitioner
MONDAY • MAY 1, 2017
Harvard Medical School Faculty
Elliott M. Antman, MD
Aaron L. Baggish, MD
Deepak L. Bhatt, MD, MPH
Ron Blankstein, MD
Marc P. Bonaca, MD, MPH
Eugene Braunwald, MD
Enrico Cagliero, MD
Susan Cheng, MD
Jean M. Connors, MD
Akshay S. Desai, MD, MPH
Laurence M. Epstein, MD
Rodney H. Falk, MD
Samuel Z. Goldhaber, MD
Michael J. Landzberg, MD
Eldrin F. Lewis, MD, MPH
Peter Libby, MD
Leonard S. Lilly, MD
Joseph Loscalzo, MD, PhD
Calum A. MacRae, MD, PhD
Laura Mauri, MD, MSc
Mandeep R. Mehra, MD, MPH
Gregory Michaud, MD
Anju Nohria, MD
Patrick O’Gara, MD
Marc A. Pfeffer, MD, PhD
Gregory Piazza, MD, MS
Jorge Plutzky, MD
Donna M. Polk, MD, MPH
Susan Redline, MD, MPH
Paul M Ridker, MD, MPH
Christian T. Ruff, MD, MPH
Benjamin M. Scirica, MD
Pinak B. Shah, MD
Piotr Sobieszczyk, MD
William G. Stevenson, MD
Garrick C. Stewart, MD
Anne Marie Valente, MD
Aaron B. Waxman, MD, PhD
CONGENITAL HEART DISEASE, PULMONARY EMBOLISM, PULMONARY
HYPERTENSION, AND SYSTEMIC ARTERIAL HYPERTENSION
Session Chair: Samuel Z. Goldhaber, MD
8:00 am
8:35 am
Philip J. Podrid, MD
Professor of Medicine
Boston University School of Medicine
Professor of Pharmacology & Experimental Therapeutics
Boston Medical Center
Management of Pulmonary Embolism and Deep Vein Thrombosis,
including Pathophysiology, Risk Stratification, Novel Oral
Anticoagulants, Thrombolytic Therapy, Pharmacomechanical Therapy
in the Cath Lab, Surgical Embolectomy, and Options for Extended
Duration Anticoagulation Samuel Z. Goldhaber, MD
Discussion, Q&A
8:45 am
Right Heart Failure Due to Congenital Heart Disease: Several CaseBased Presentations Michael J. Landzberg, MD
9:20 am
Discussion, Q&A
9:30 am
10:05 am
10:15 am
10:40 am
11:15 am
Guest Faculty
Joseph A. Hill, MD, PhD
Professor, Department of Internal Medicine
James T. Willerson, M.D., Distinguished Chair in Cardiovascular Diseases
Frank M. Ryburn, Jr. Chair in Heart Research
Chief, Division of Cardiology
Director, Harry S. Moss Heart Center
UT Southwestern Medical Center
BOSTON, MA
Pulmonary Hypertension: Classification, Diagnosis, and
Emerging Therapies Aaron B. Waxman, MD, PhD
Discussion, Q&A
Coffee Break (refreshments provided)
Systemic Arterial Hypertension: What Drugs and What Parameters
Should We Use for Blood Pressure Control?
Susan Cheng, MD
Discussion, Q&A
FEATURED PRESENTATION: DEPARTMENT OF MEDICINE CHAIR’S LECTURE
Session Chair: Calum A. MacRae, MD, PhD
11:25 am
Noon
12:10 pm
Precision Cardiovascular Medicine: Case Study of a Patient with
Premature Atherothrombosis—Bedside-to-Bench Analysis and
Bench-to-Bedside Implications for Care Joseph Loscalzo, MD, PhD
Discussion, Q&A
Lunch Break
INTERSECTION OF CARDIOVASCULAR MEDICINE,
INTERNAL MEDICINE, AND HIGH-RISK OBSTETRICS
Session Chairs: Samuel Z. Goldhaber, MD and Patrick O’Gara, MD
1:20 pm
1:55 pm
2:05 pm
2:40 pm
2:50 pm
3:25 pm
What the General Cardiologist Needs to Know about Amyloidosis
Rodney H. Falk, MD
Discussion, Q&A
Pericardial Disease: Etiology, Anti-Inflammatory Therapy, Duration
of Therapy, Use of Colchicine, and Tips on Weaning from Prednisone
Leonard S. Lilly, MD
Discussion, Q&A
Cardiovascular Management of High-Risk Pregnancy
Anne Marie Valente, MD
Discussion, Q&A
3:35 pm
Snack Break and Transition to Breakout Sessions
3:50 pm
Session I: Rapid-Fire ECG Quiz Philip J. Podrid, MD
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD
BREAKOUT SESSIONS I/II/III
4:40 pm
Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
Transition
4:50 pm
Session I: Rapid-Fire ECG Quiz Philip J. Podrid, MD
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD
5:40 pm
Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
Transition
5:50 pm
Session I: Rapid-Fire ECG Quiz Philip J. Podrid, MD
Session III: Case-Based Geriatric Cardiology Conundrums
Susan Cheng, MD
6:40 pm Session II: Case-Based Stroke Prevention in Atrial Fibrillation
Christian T. Ruff, MD, MPH
ADJOURN DAY 2
Cardiovascular Medicine 2017
APRIL 30 - MAY 4
Updates for the Practitioner
“Among the many bullet points I have taken from
this phenomenal program: maximizing beta
blockade in CHF clinic; more use of bisoprolol;
and improved assessment strategies in PVD.”
“I am utilizing the ideas presented in this course
to start an outpatient heart failure clinic to
decrease readmissions.”
TUESDAY • MAY 2, 2017
ELECTROPHYSIOLOGY
Session Chairs: Laurence M. Epstein, MD and William G. Stevenson, MD
8:00 am
8:35 am
8:45 am
9:20 am
9:30 am
“My practice has updated its use of platelet
assays, its approach to STEMI/ NSTEMI
treatment options and diagnosis, and the
evaluation of surgical therapy.”
“The availability of the faculty at this course to
answer questions was truly remarkable.”
“I have new insight into prevention of
heart failure prior to onset.”
“The bench-to-bedside approach to teaching—
pulling disease pathophysiology from the cellular/
biochemical level and expanding it to human
case examples and to the public health
sphere—was exceptional.”
BOSTON, MA
10:05 am
10:15 am
EP Device and Lead Management Principles for the General
Cardiologist and Internist
Laurence M. Epstein, MD
Discussion Q&A
Ventricular Tachycardia “Storm” and Other EP Emergencies:
A Case-Based Approach to Management
William G. Stevenson, MD
Discussion, Q&A
Rapid-Fire Case-Based Arrhythmia Quiz
Laurence M. Epstein, MD
Discussion, Q&A
Coffee Break (refreshments provided)
MULTIMODALITY CARDIOVASCULAR IMAGING
Session Chairs: Donna M. Polk, MD, MPH and Ron Blankstein, MD
10:40 am
11:15 am
11:25 am Noon
Rapid-Fire Echocardiography Cases, including Diastolic Dysfunction,
ECHO-Contrast, and Transesophageal ECHO
Donna M. Polk, MD, MPH
Discussion, Q&A
How to Select, Use, and Integrate the Results of Cardiovascular
Imaging Tests: CT, Magnetic Resonance, and Nuclear Imaging
Ron Blankstein, MD
Discussion, Q&A
12:10 pm
Lunch Break
INTERSECTION OF CARDIOVASCULAR AND INTERNAL MEDICINE
Session Chairs: Samuel Z. Goldhaber, MD and Peter Libby, MD
1:20 pm
1:55 pm
2:05 pm
2:40 pm
2:50 pm
Sleep-Disordered Breathing: Relationship to Heart Failure, Atrial
Fibrillation, and Pulmonary Hypertension
Susan Redline, MD, MPH
Discussion, Q&A
What Cardiovascular Specialists Need to Know about Diabetes
Mellitus Enrico Cagliero, MD
Discussion, Q&A
Snack Break and Transition to Breakout Sessions
BREAKOUT SESSIONS IV/V/VI
3:00 pm
3:50 pm
4:00 pm
4:50 pm
5:00 pm
5:50 pm Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD, MS
Session V: Difficult Dilemmas That My Patients and I Have
Confronted—Part I
Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD
Transition
Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD, MS
Session V: Difficult Dilemmas That My Patients and I Have
Confronted—Part I
Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD
Transition
Session IV: Bleeding and Clotting Cases
Gregory Piazza, MD, MS
Session V: Difficult Dilemmas That My Patients and I Have
Confronted—Part I Patrick O’Gara, MD
Session VI: Rapid-Fire Cases from the Vascular Diagnostic Laboratory
Piotr Sobieszczyk, MD
ADJOURN DAY 3
Cardiovascular Medicine 2017
APRIL 30 - MAY 4
Updates for the Practitioner
Learning Objectives
WEDNESDAY • MAY 3, 2017
Upon completion of this course, participants will be able to:
• Apply new guidelines and practice recommendations for lipid
therapy with PCSK9 inhibitors and advanced heart failure
therapies.
• Utilize methods for optimal integration of multimodality
cardiovascular imaging with magnetic resonance, coronary CT,
nuclear medicine, and echocardiography.
• Develop strategies to troubleshoot problems with pacemakers
and ICDs.
• Utilize new strategies for minimizing hospital readmission rates
for congestive heart failure.
• Determine when to refer patients for combination therapy of
idiopathic pulmonary hypertension and which combinations of
drugs are most successful.
ACUTE CORONARY SYNDROMES
Session Chair: Samuel Z. Goldhaber, MD
8:00 am
Acute Coronary Syndromes: Guideline Updates and Novel, Emerging
Therapies Elliott M. Antman, MD
8:35 am
Discussion, Q&A
CARDIOHEMATOLOGY
Session Chairs: Samuel Z. Goldhaber, MD and Jean M. Connors, MD
8:45 am
9:20 am
9:30 am
10:05 am
10:15 am
10:40 am
• Discuss cardiovascular safety in athletes.
• Manage cardiovascular problems in high-risk pregnancies.
• Apply advances in amyloidosis management to their daily
practice.
• Integrate updates in pericardial diseases into their practice.
BOSTON, MA
11:15 am
Heparin Monitoring: PTT, ACT, Anti-XA, TEG—Which Strategy Is Best
for the General Cardiologist? Jean M. Connors, MD
Discussion, Q&A
Triple Therapy with Anticoagulation Plus Dual Antiplatelet Therapy—
What Duration of Dual Antiplatelet Therapy? Which Antiplatelet
Agents Should We Select? Is There a Role for Proton Pump
Inhibitors? Deepak L. Bhatt, MD, MPH
Discussion, Q&A
Coffee Break (refreshments provided)
NOACs: Randomized Trials versus Real World Evidence for Safety
and Efficacy, Management of Bleeding Complications, and Role of
Antidotes Samuel Z. Goldhaber, MD
Discussion, Q&A
KENNETH L. BAUGHMAN, MD MEMORIAL LECTURE
Session Chair: Patrick O’Gara, MD
11:25 am
12:15 pm
12:25 pm
Cardiovascular Safety in Athletes Aaron L. Baggish, MD
Discussion, Q&A
Lunch Break
STATE-OF-THE-ART LECTURES
Session Chairs: Samuel Z. Goldhaber, MD and Peter Libby, MD
1:35 pm
2:10 pm
2:20 pm
2:55 pm
Challenges for Cardiac Intensive Care: Cooling Protocols, Ventilator
Settings, Extracorporeal Membrane Oxygenation, Resuscitation
Science Benjamin M. Scirica, MD
Discussion, Q&A
Novel Ways to Reduce Cardiovascular Risk: Bariatric Surgery and
Treatment of Metabolic Syndrome Deepak L. Bhatt, MD, MPH
Discussion, Q&A
3:05 pm
Snack Break and Transition to Breakout Sessions
3:20 pm
Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
BREAKOUT SESSIONS VII/VIII/IX
4:10 pm
Program changes/substitutions may be made without notice. To view the most up-to-date
version of the course program, please visit the course website.
DISCLOSURE POLICY: Harvard Medical School (HMS) adheres to all ACCME Essential
Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the
content of a CME activity (e.g., planners, faculty, reviewers, and others) disclose all
relevant financial relationships with commercial entities so that HMS may identify and
resolve any conflicts of interest prior to the activity. These disclosures will be provided in
the activity materials along with disclosure of any commercial support received for the
activity. Additionally, faculty members have been instructed to disclose any limitations
of data and unlabeled or investigational uses of products during their presentations.
4:20 pm
5:10 pm
5:20 pm
6:10 pm Session VIII: Cardio-Oncology Cases Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have
Confronted—Part II Patrick O’Gara, MD
Transition
Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
Session VIII: Cardio-Oncology Cases Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have
Confronted—Part II Patrick O’Gara, MD
Transition
Session VII: Cardiac Intensive Care Unit Cases
Benjamin M. Scirica, MD
Session VIII: Cardio-Oncology Cases Anju Nohria, MD
Session IX: Difficult Dilemmas That My Patients and I Have
Confronted—Part II Patrick O’Gara, MD
ADJOURN DAY 4
Register at Cardiovascular.HMSCME.com
Cardiovascular Medicine 2017
APRIL 30 - MAY 4
Updates for the Practitioner
BOSTON, MA
THURSDAY • MAY 4, 2017
ADVANCED HEART FAILURE AND CARDIOMYOPATHY
Session Chair: Mandeep R. Mehra, MD, MPH
8:00 am
8:35 am
8:45 am
9:20 am
9:30 am
10:05 am
10:15 am
10:40 am
11:15 am
Advanced Heart Failure: State of the Art, including Mechanical
Circulatory Support
Mandeep R. Mehra, MD, MPH
Discussion, Q&A
Optimizing Medical Therapy of Hospitalized Patients with
Advanced Heart Failure: Tricks of the Trade
Garrick C. Stewart, MD
Discussion, Q&A
Preventing Readmission of Advanced Heart Failure Patients within
30 Days of Discharge: Optimizing Disease Management with
Implementation Science and Therapies such as CardioMEMS® and
Entresto®
Akshay S. Desai, MD, MPH
Discussion, Q&A
Coffee Break (refreshments provided)
Clinical Importance of Assessing Quality of Life in Advanced Heart
Failure Patients: Correlation with Prognosis and Association with
Socioeconomic and Racial/Ethnic/Cultural Considerations
Eldrin F. Lewis, MD, MPH
Discussion, Q&A
CATH LAB REVASCULARIZATION OF ACUTE MI: CHANGE IN PHILOSOPHY
REGARDING EXTENT OF REVASCULARIZATION?
Session Chair: Gregory Piazza, MD, MS
11:25 am
Noon
Acute Coronary Syndromes: Revascularization in the Cardiac Cath
Lab—Culprit Artery Only or ‘Complete Revascularization’?
Laura Mauri, MD, MSc
Discussion, Q&A
VASCULAR MEDICINE
Session Chairs: Samuel Z. Goldhaber, MD and Gregory Piazza, MD, MS
12:10 pm
Updates to diagnose, treat, and improve
care for patients with:
12:45 pm
12:55 pm
1:55 pm
• Acute coronary syndromes
• Congestive heart failure
• Atherosclerosis and inflammation
2:30 pm
2:40 pm
3:15 pm
• Atrial fibrillation
• Congenital heart disease
• Diseases of the aorta
3:25 pm
4:00 pm
4:10 pm
• Pulmonary thromboembolism
• Venous thromboembolism
4:45 pm
• Pulmonary hypertension
5:00 pm
4:55 pm
Vasculitis, including Takayasu’s Arteritis, Giant Cell Arteritis,
Thromboangiitis Obliterans (Buerger’s Disease), and Kawasaki
Disease in the Adult
Gregory Piazza, MD, MS
Discussion, Q&A
Lunch Break
“Code Aorta”: How to Organize a Strategic Multidisciplinary
Response to a Potentially Fatal Vascular Emergency: Initial Results
and Rapid-Fire Case Presentations
Marc P. Bonaca, MD, MPH
Discussion, Q&A
Peripheral Arterial Disease: Pathophysiology, Intermittent
Claudication, and Critical Limb Ischemia
Gregory Piazza, MD, MS
Discussion, Q&A
Cardiovascular Benefits and Risks of Anti-Diabetic Drugs
Marc A. Pfeffer, MD, PhD
Discussion, Q&A
Ongoing Potential Practice-Changing Trials in Pulmonary
Embolism and Deep Vein Thrombosis: Do You Worship at the
Altar of P < 0.05?
Samuel Z. Goldhaber, MD
Discussion, Q&A
General Discussion, Wrap-up
ADJOURN DAY 5
• Diseases of the peripheral arteries and veins
Register at Cardiovascular.HMSCME.com
Register at Cardiovascular.HMSCME.com
Cardiovascular Medicine 2017
Register after
February 28,
2017
Register on or before
February 28, 2017
(SAVE $200)
Physicians
$1,595
$1,395
Allied Health Professionals, Residents, and Fellows
$1,395
$1,195
(Course #732555-1702)
Your tuition includes continental breakfast, morning and afternoon coffee breaks,
complimentary Internet in the meeting room, course materials on flash drive, and a
printed program book.
Registration, Payment, Confirmation and Refund Policy
Registrations for Harvard Medical School CME programs are made via our secure online
registration system. To register for this course, please visit the course website.
At the end of the registration process, a $5 non-refundable processing fee will be added to your
registration, and you will have the choice of paying by check or credit card (Visa, MasterCard, or
American Express). If you are paying by check, the online registration system will provide you
with instructions and a printable form for remitting your course fees by check. Postal, telephone,
fax, and cash-payment registrations are not accepted. Fees shown in USD.
Upon receipt of your paid registration, an email confirmation from the HMS DCE office will be
sent to you. Be sure to include an email address that you check frequently. Your email address
is used for critical information, including registration confirmation, evaluation, and certificate.
Refunds, less an administrative fee of $75, will be issued for all cancellations received two
weeks prior to the start of the course. Refund requests must be received by postal mail, email,
or fax. No refund will be issued should cancellation occur less than two weeks prior. “No shows”
are subject to the full course fee and no refunds will be issued once the conference has started.
VENUE
The Fairmont Copley Plaza
138 St. James Avenue
Boston, Massachusetts
1-866-540-4417
ACCOMMODATIONS
A limited number of rooms have been reserved at the Fairmont Copley Plaza Hotel until April 7, 2017.
When calling the hotel, be sure to specify that you are enrolled in this activity to receive a reduced
room rate. Hotel arrangements can also be made online before April 7 by going to the course website
and clicking on the course-specific link on the Venue page.
Please do not make non-refundable travel arrangements until you have received an email from
our office confirming your paid registration.
INQUIRIES
Call 617-384-8600 Mon-Fri 9am – 5pm EST. Send e-mail to [email protected].